When treating obesity, semaglutide may be associated with a reduced fracture risk compared with sleeve gastrectomy.

Fracture risk may be higher after bariatric surgery than after treatment with weight-loss drugs, propensity-score matched ...

In a retrospective cohort study using propensity matching, among patients with obesity, those taking semaglutide had lower ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...